These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 27517517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Total glucosides of paeony (TGP) alleviates constipation and intestinal inflammation in mice induced by Sjögren's syndrome.
    Liu G, Wang Z, Li X, Liu R, Li B, Huang L, Chen Y, Zhang C, Zhang H, Li Y, Chen Y, Yin H, Fang W.
    J Ethnopharmacol; 2020 Oct 05; 260():113056. PubMed ID: 32525066
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study.
    Li CL, He J, Li ZG, Zheng LW, Hua H.
    J Craniomaxillofac Surg; 2013 Oct 05; 41(7):610-5. PubMed ID: 23333492
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of iguratimod on patients with primary Sjögren's syndrome: a randomized, placebo-controlled clinical trial.
    Shao Q, Wang S, Jiang H, Liu L.
    Scand J Rheumatol; 2021 Mar 05; 50(2):143-152. PubMed ID: 33118847
    [Abstract] [Full Text] [Related]

  • 11. Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.
    Zhu Q, Qi X, Wu Y, Wang K.
    Int Urol Nephrol; 2016 Nov 05; 48(11):1873-1880. PubMed ID: 27342654
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Total glucosides of paeony alleviates experimental Sjögren's syndrome through inhibiting NLRP3 inflammasome activation of submandibular gland cells.
    Jiang T, Guo J, Wang Y, Wu H, Chen Y, Wang S, Zhang H, Long Q, Yao G.
    Clin Exp Rheumatol; 2023 Dec 05; 41(12):2502-2510. PubMed ID: 38149512
    [Abstract] [Full Text] [Related]

  • 15. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Dörner T, Posch MG, Li Y, Petricoul O, Cabanski M, Milojevic JM, Kamphausen E, Valentin MA, Simonett C, Mooney L, Hüser A, Gram H, Wagner FD, Oliver SJ.
    Ann Rheum Dis; 2019 May 05; 78(5):641-647. PubMed ID: 30826774
    [Abstract] [Full Text] [Related]

  • 16. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J.
    Arthritis Rheum; 2004 Apr 05; 50(4):1270-6. PubMed ID: 15077311
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR.
    Arthritis Rheum; 2004 Jul 05; 50(7):2240-5. PubMed ID: 15248223
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan 05; 95(1):38-44. PubMed ID: 12539025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.